'Nimbleness Is Needed In Follow-on Biologics'

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p83
Trade Publication
The article reports on the white paper from Thomson Reuters Corp. which reveals that companies have increased their biologics development in the U.S.


Related Articles

  • Creativity, collaboration on minds of biopharmas in 2013 dealmaking. Powers, Marie // BioWorld Insight;1/27/2014, Vol. 22 Issue 4, p1 

    The article offers an analysis of the growth in the pharmaceutical industry of the U.S. in 2013. Topics discussed include mergers and acquisitions in the industry, emergence of biotechnology companies and growth in initial public offerings and licensing agreements. According to an analysis of...

  • 'Conduct Risk' Stymies Financial Cos. Mont, Joe // Compliance Week;Mar2015, Vol. 12 Issue 134, p8 

    The article discusses the Thomson Reuters Conduct Risk Report study which focuses on teh impacts of conduct risks in financial services industries in the U.S. and outlines the lack of working definitions by respondents in compliance.

  • High-Yield Debt Has Record Quarter. Platt, Gordon // Global Finance;May2010, Vol. 24 Issue 5, p95 

    The article reports on the 75.5 billion U.S. dollar of global corporate high-yield debt as one of the highest quarterly debt recorded by Thomson Reuters in the U.S. It has been stated that the materials sector has been considered as one of the most active for high-yield debt issuance. Moreover,...

  • Who's shaping professional opinions about drugs and therapies?  // European Pharmaceutical Executive;Nov/Dec2006, p26 

    The article reports on the research conducted by Thomson Pharma showing the bigger efforts of GlaxoSmithKline to publish scientific research between June and August 2006. The study was done through the Thomson Message Mapping System which measures the impact of pharmaceutical product messaging...

  • M&A Surge Predicted for Generics Industry.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p58 

    The article presents a study by Thomson Reuters Corp. called Gaining Market Share in the Generic Drug Industry Through Acquisitions and Partnerships which reveals that a wave of mergers & acquisitions (M&As) awaits the generic pharmaceutical industry buffeted by price cuts in the U.S.

  • The Brazilian Journal of Pulmonology and international databases. Ribeiro Carvalho, Carlos Roberto // Jornal Brasileiro de Pneumologia;sep/out2013, Vol. 39 Issue 5, p529 

    No abstract available.

  • Take that recession. Pallerino, Michael J. // Commercial Construction & Renovation;Sep/Oct2012, Vol. 11 Issue 5, p6 

    The article presents updates on the hospitality, restaurant and retail industries in the U.S. as of September 2012. U.S. restaurant companies are forecasted to record a combined same-store sales increase of 2.8 percent for the third quarter, according to Thomson Reuters Corp. More favorable...

  • Weekly Calendar Bulks Up. Albano, Christine // Bond Buyer;10/4/2010, Vol. 374 Issue 33393, p1 

    The article offers news briefs related to securities trading in the U.S. According to Ipreo LLC, $13.13 billion dollars worth of long term volume injected during the first week of the fourth quarter of 2010 is projected to re-energize the primary market. In Pennsylvania, about one billion...

  • Philadelphia Fed Index Drops to 6.3 in Jan. from 24.3 in Dec. Siegel, Gary // Bond Buyer;1/16/2015, Vol. 1 Issue F303, p1 

    The region's manufacturing sector expanded at a slower pace in January, as the general business conditions index dropped 6.3 from 24.3 in December, this month's Federal Reserve Bank of Philadelphia Report on Business indicates.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics